Transcriptomics

Dataset Information

0

Targeting polyamine metabolism and eIF5A hypusination in pediatric acute myeloid leukemia


ABSTRACT: Pediatric acute myeloid leukemia (AML) is a devasting disease with 5-year survival outcomes of approximately 60%. Therefore, there is an urgent need to develop novel therapies for pediatric AML patients. Numerous studies have demonstrated that cellular metabolism is a key vulnerability in adult AML; however, we understand very little about metabolism in pediatric AML. Using pediatric AML patient derived xenograft models, we demonstrate that polyamine metabolism is a pharmacologically targetable vulnerability of pediatric AML cells. Further, depletion of polyamines sensitizes pediatric AML cells to chemotherapy in vitro and in vivo. Mechanistically, polyamine depletion causes reduced protein synthesis through decreased hypusination of translational elongation factor eIF5A. Pharmacologic polyamine depletion and inhibition of eIF5A hypusination result in reduced protein synthesis and decreased expression of cell cycle regulatory proteins resulting in a G1 cell cycle arrest and eventual cell death through apoptosis. In summary, this study reveals polyamine metabolism and hypusination of eIF5A as a vulnerability in pediatric AML that can be targeted using clinically trackable approaches.

ORGANISM(S): Homo sapiens

PROVIDER: GSE342172 | GEO | 2026/08/02

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
GSE342172_RNA-Seq_ALL_counts.txt.gz Txt
GSE342172_Riboseq_ALL_counts.txt.gz Txt
Items per page:
1 - 3 of 3

Similar Datasets

2025-05-06 | GSE266331 | GEO
2025-04-24 | GSE272725 | GEO
2022-01-01 | GSE174041 | GEO
2022-01-01 | GSE176329 | GEO
2024-03-31 | GSE244063 | GEO
2024-07-10 | GSE243344 | GEO
2023-01-25 | MSV000091139 | MassIVE
2024-08-14 | MTBLS10690 | MetaboLights
| PRJNA662095 | ENA
2016-07-09 | PXD000880 | Pride